The Company’s issued share capital consists of 182,272,607 ordinary shares with a nominal value of 10p each (“Ordinary Shares”), each share having equal voting rights. The Company does not hold any Ordinary Shares in treasury.
An Employee Benefit Trust holds 2,709,126 Ordinary Shares. The Employee Benefit Trust abstains from voting.
So far as the Company is aware, the persons listed below are interested in 3% or more of the Company’s issued share capital.
In accordance with AIM Rule 26 in so far as the Company is aware the percentage of the Company’s issued share capital that is not in public hands is 38.59%.
The Directors of the Company are interested in a total of 48,078,147 Ordinary Shares.
The share capital numbers and interests set out in this page were last updated on 10th April 2024.
The Company’s issued share capital consists of 139,086,408 ordinary shares with a nominal value of 10p each (“Ordinary Shares”), each share having equal voting rights. The Company does not hold any Ordinary Shares in treasury.
An Employee Benefit Trust holds 5,010,158 Ordinary Shares. The Employee Benefit Trust abstains from voting.
So far as the Company is aware, the persons listed below are interested in 3% or more of the Company’s issued share capital.
In accordance with AIM Rule 26 in so far as the Company is aware the percentage of the Company’s issued share capital that is not in public hands is 39.57%
The Directors of the Company are interested in a total of 1,723358 Ordinary Shares.
The share capital numbers and interests set out in this page were last updated on 9th June 2022.
NOTE: Unless otherwise stated, the shareholding figures set out above have been extracted from notifications of major holdings (TR-1 forms) received from shareholders and subsequently announced to the market by the Company. Readers should note that, in accordance with certain exemptions to the Disclosure Guidance and Transparency Rules, qualifying entities are only required to submit TR-1s form to the Company when their holding reaches, or falls below, 5% intervals.
The below list shows the name of the Shareholder alongside the amount of shares as ordinary shares as a percentage of issued shared capital.
| Lombard Odier Investment Managers | 25.75% | |
| Otus Capital Management | 10.73% | |
| Aviva Investors | 8.05% | |
| JO Hambro Capital | 7.90% | |
| River & Mercantile Asset Management | 6.18% | |
| Tellworth Investments | 5.35% | |
| Cazenove Capital Management | 4.72% | |
| Baillie Gifford | 3.97% | |
| Sarasin & Partners | 3.93% | |
The below list shows the name of the Shareholder alongside the amount of shares as ordinary shares as a percentage of issued shared capital.
| Lombard Odier Investment Managers | 14.17% | ||
| Aviva Investors | 10.53% | ||
| Otus Capital Management | 10.15% | ||
| JO Hambro Capital | 8.35% | ||
| Tellworth Investments | 8.01% | ||
| River & Mercantile Asset Management | 6.53% | ||
| AXA Framlington Investment Managers | 4.15% | ||
| Sarasin & Partners | 3.96% | ||
| Cazenove Capital Management | 3.95% | ||
| Baillie Gifford | 3.49% |
SiS (Science in Sport®) PLC is a leading sports nutrition business that develops, manufactures and markets science-led nutrition products for professional athletes, sports and fitness enthusiasts and the active lifestyle community. SiS (Science in Sport®) PLC (company number 08535116) was founded in 1992 and is headquartered in London, EC1N. Our manufacturing facility is in Blackburn, and all our products are thoroughly tested and certified through the Informed-Sport programme
